CUMBERLAND PARTNERS LTD – Eli Lilly and Company Transaction History
CUMBERLAND PARTNERS LTD portfolio value:
$7.44M
portfolio value
CUMBERLAND PARTNERS LTD quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +9.51% | 2K shares | 629K | $323.35 | 23.03K |
Q2 2022 | share | Increase | +1.57% | 325 shares | 889K | $324.23 | 21.03K |
Q1 2022 | share | Increase | +140.99% | 12.11K shares | 3.55M | $286.37 | 20.70K |
Q4 2021 | share | Increase | 0.00% | 8.59K shares | 2.37M | $277.25 | 8.59K |
Q1 2021 | share | Decrease | -100.00% | -7.54K shares | -1.27M | $184.81 | 0 |
Q4 2020 | share | Increase | +42.49% | 2.25K shares | 490K | $166.32 | 7.54K |
Q3 2020 | share | Increase | 0.00% | 5.29K shares | 784K | $145.05 | 5.29K |
Q2 2020 | share | Decrease | -100.00% | -5.49K shares | -762K | $160.1 | 0 |
Q1 2020 | share | Decrease | -25.71% | -1.9K shares | -209K | $134.64 | 5.49K |
Q4 2019 | share | Decrease | -0.87% | -65 shares | 137K | $126.91 | 7.39K |
Q3 2019 | share | Increase | +33.36% | 1.86K shares | 215K | $107.36 | 7.45K |
Q2 2019 | share | Decrease | -9.14% | -562 shares | -179K | $105.74 | 5.59K |
Q1 2019 | share | Increase | +27.63% | 1.33K shares | 240K | $123.17 | 6.15K |
Q4 2018 | share | Increase | +23.59% | 920 shares | 139K | $109.26 | 4.82K |
Q3 2018 | share | 0.00% | 0 shares | 86K | $100.8 | 3.9K | |
Q2 2018 | share | Increase | 0.00% | 3.9K shares | 333K | $79.72 | 3.9K |